583878-42-6 Usage
General Description
Ethyl 4-Chloro-6-methyl-2-(methylthio)pyrimidine-5-carboxylate is an organic compound with the molecular formula C10H12ClN3O2S. It is a pyrimidine derivative with a chloro and methylthio group attached to the 4 and 6 positions, respectively. The ethyl ester group is attached to the carboxylate group on the 5 position of the pyrimidine ring. Ethyl 4-Chloro-6-methyl-2-(methylthio)pyrimidine-5-carboxylate is used in the synthesis of various pharmaceuticals and agrochemicals. It has potential applications in the field of medicinal and agricultural chemistry for the development of new drugs and pesticides.
Check Digit Verification of cas no
The CAS Registry Mumber 583878-42-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,3,8,7 and 8 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 583878-42:
(8*5)+(7*8)+(6*3)+(5*8)+(4*7)+(3*8)+(2*4)+(1*2)=216
216 % 10 = 6
So 583878-42-6 is a valid CAS Registry Number.
InChI:InChI=1S/C9H11ClN2O2S/c1-4-14-8(13)6-5(2)11-9(15-3)12-7(6)10/h4H2,1-3H3
583878-42-6Relevant articles and documents
KINASE INHIBITORS
-
Page/Page column 46, (2011/05/11)
The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoim
CHEMICAL COMPOUNDS
-
Page/Page column 39, (2010/04/03)
The invention is directed to pyrido[4,3-d]pyrimidin-5(6H)-one derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R1, R2, R3, and R4 are defined below. The compound
PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF PI3K-ALPHA FOR THE TREATMENT OF CANCER
-
Page/Page column 74, (2008/12/08)
The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer.